FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37708383> ?p ?o ?g. }

• Q37708383 description "article científic" @default.
• Q37708383 description "article scientifique" @default.
• Q37708383 description "articolo scientifico" @default.
• Q37708383 description "artigo científico" @default.
• Q37708383 description "artículu científicu espublizáu en 2017" @default.
• Q37708383 description "bilimsel makale" @default.
• Q37708383 description "scientific article published on 16 March 2017" @default.
• Q37708383 description "vedecký článok" @default.
• Q37708383 description "vetenskaplig artikel" @default.
• Q37708383 description "videnskabelig artikel" @default.
• Q37708383 description "vědecký článek" @default.
• Q37708383 description "wetenschappelijk artikel" @default.
• Q37708383 description "wissenschaftlicher Artikel" @default.
• Q37708383 description "наукова стаття, опублікована в березні 2017" @default.
• Q37708383 description "научни чланак" @default.
• Q37708383 description "مقالة علمية نشرت في 16 مارس 2017" @default.
• Q37708383 name "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 name "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 name "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 type Item @default.
• Q37708383 label "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 label "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 label "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 prefLabel "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 prefLabel "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 prefLabel "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea." @default.
• Q37708383 P1433 Q37708383-292AEF46-2195-4785-9811-DEDA1C7F016C @default.
• Q37708383 P1476 Q37708383-6141E4B2-1AEA-4BFD-8610-D85050386FC0 @default.
• Q37708383 P2093 Q37708383-5E2B3BB9-E7DD-4BA6-8CB7-43FB5E22F91A @default.
• Q37708383 P2093 Q37708383-8842A03A-AF52-4488-97C6-0BE456540209 @default.
• Q37708383 P2093 Q37708383-C51E3D4B-8BFF-4311-BF5B-F63A8B9AD5FA @default.
• Q37708383 P2093 Q37708383-C6DB1422-440D-4B63-BD36-9E1A8BAB7CD8 @default.
• Q37708383 P2093 Q37708383-F63CED38-B7BF-42B5-A25E-3823CB18A686 @default.
• Q37708383 P2860 Q37708383-12015DA8-6A03-4329-B2FD-8B0B96E18C63 @default.
• Q37708383 P2860 Q37708383-122BDC50-036C-49FE-A23C-6A0E8CF639A9 @default.
• Q37708383 P2860 Q37708383-1385D431-1CA7-4E84-A8CA-F26F0047B786 @default.
• Q37708383 P2860 Q37708383-24AB47F0-EF05-48D3-A5D6-3CE7CB5D7BFC @default.
• Q37708383 P2860 Q37708383-29854D9E-C04B-4F99-B3D1-02686D123762 @default.
• Q37708383 P2860 Q37708383-299033A3-AF70-4376-AE69-4450BD0E96F8 @default.
• Q37708383 P2860 Q37708383-2D5A6D87-6FB2-4521-8C4D-C2A6275253EB @default.
• Q37708383 P2860 Q37708383-3C95E038-0F2C-44D7-993D-432E4DD56BB6 @default.
• Q37708383 P2860 Q37708383-4378AAB7-9AB8-435F-84F2-26AB843C96FF @default.
• Q37708383 P2860 Q37708383-43FEB9AD-987F-4937-BD59-58D672EA3DC7 @default.
• Q37708383 P2860 Q37708383-4C129232-C975-49AB-B388-2432C65D90B5 @default.
• Q37708383 P2860 Q37708383-57CFCEF7-F731-434F-91EB-C24F0212BD9E @default.
• Q37708383 P2860 Q37708383-58DE84C7-E93F-4D03-B2E7-A7827D611E08 @default.
• Q37708383 P2860 Q37708383-59972263-0DE7-4E39-BF1A-8DB5ABCD814E @default.
• Q37708383 P2860 Q37708383-6173D774-8281-4A53-A015-9114405C421E @default.
• Q37708383 P2860 Q37708383-61B7C89C-F496-4FE2-BC55-383366602A16 @default.
• Q37708383 P2860 Q37708383-6301C50D-67B6-4B2F-B99F-B3F433AD42EF @default.
• Q37708383 P2860 Q37708383-64CE4A24-216E-445D-94DC-767F132A5FCE @default.
• Q37708383 P2860 Q37708383-66ABF608-CE90-4BB5-8458-992DE9C272AB @default.
• Q37708383 P2860 Q37708383-7BA00B45-4D90-43C7-8A4A-03FB9D04DC4B @default.
• Q37708383 P2860 Q37708383-8610F85A-8389-410D-B6FC-21851EF79877 @default.
• Q37708383 P2860 Q37708383-95BF5170-0E30-46BA-8B74-787B77ABEA8C @default.
• Q37708383 P2860 Q37708383-9712D313-B411-4575-BF09-3B5178656438 @default.
• Q37708383 P2860 Q37708383-A9422048-4392-44F4-BFA1-885138AE65B2 @default.
• Q37708383 P2860 Q37708383-AC347F0C-6871-46C6-858F-246343EF56AC @default.
• Q37708383 P2860 Q37708383-C2CAAB38-7F9C-4180-97C0-9FC9B7E99674 @default.
• Q37708383 P2860 Q37708383-C6009378-F8A6-4A5D-B88C-A4D2D0AB4E29 @default.
• Q37708383 P2860 Q37708383-DBF8AD86-E773-44EE-9238-D776F7E2FDAF @default.
• Q37708383 P2860 Q37708383-E24F7A2D-0669-4401-8A1A-7D2C3156E88A @default.
• Q37708383 P2860 Q37708383-E30AD7B7-FE5B-4513-91F8-AEB136F54C13 @default.
• Q37708383 P2860 Q37708383-E61AFA1F-DA14-4D16-A8EF-B32BA0B46D02 @default.
• Q37708383 P2860 Q37708383-E64083AF-8034-418E-8FF2-6B689D7B45C5 @default.
• Q37708383 P2860 Q37708383-FB2B6D96-81DD-4DD8-B8FC-8836079B96CA @default.
• Q37708383 P2860 Q37708383-FBDDA712-17A2-4D45-AEA1-27E76981484E @default.
• Q37708383 P2888 Q37708383-5D96D854-2676-4547-BA96-F31BCDAAFECF @default.
• Q37708383 P304 Q37708383-100ABAE7-6828-414A-9E3C-2F598241B332 @default.
• Q37708383 P31 Q37708383-AFA7C816-032B-4888-A9DE-843D798E6D87 @default.
• Q37708383 P356 Q37708383-ABFE3F32-E7DA-495A-ABF6-68280F2CBE96 @default.
• Q37708383 P407 Q37708383-651F2A02-F0EE-46C3-A41B-04CB91443B3A @default.
• Q37708383 P478 Q37708383-45934605-3E72-421E-930F-42A714FF616B @default.
• Q37708383 P50 Q37708383-C9DED4DD-0560-47E4-8148-6F4D243F05E4 @default.
• Q37708383 P577 Q37708383-83F2A807-4CFA-407E-A255-BADF0D38EEE7 @default.
• Q37708383 P698 Q37708383-76CCB75A-D5D5-44B0-AED9-0ABE1096D151 @default.
• Q37708383 P921 Q37708383-09B27B39-7DDE-4361-B8EB-4C4C767B9018 @default.
• Q37708383 P921 Q37708383-36DF3326-A4FB-4C5D-8388-7FD4784DD9E6 @default.
• Q37708383 P921 Q37708383-EC3E70CA-DE53-452F-AD70-2B9E3372C030 @default.
• Q37708383 P932 Q37708383-C862B565-5DBC-4CFC-BA8D-8A813947CEAA @default.
• Q37708383 P356 S13030-017-0093-9 @default.
• Q37708383 P698 28331539 @default.
• Q37708383 P1433 Q15762198 @default.
• Q37708383 P1476 "Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea" @default.
• Q37708383 P2093 "Akito Nishida" @default.
• Q37708383 P2093 "Hiraku Akiho" @default.
• Q37708383 P2093 "Kei Matsueda" @default.
• Q37708383 P2093 "Shin Fukudo" @default.
• Q37708383 P2093 "Yoshihiro Nakashima" @default.
• Q37708383 P2860 Q29615569 @default.
• Q37708383 P2860 Q29620328 @default.
• Q37708383 P2860 Q30382064 @default.
• Q37708383 P2860 Q33701309 @default.
• Q37708383 P2860 Q33828467 @default.
• Q37708383 P2860 Q34020205 @default.
• Q37708383 P2860 Q34395481 @default.
• Q37708383 P2860 Q34567301 @default.
• Q37708383 P2860 Q34626602 @default.
• Q37708383 P2860 Q35167963 @default.
• Q37708383 P2860 Q35358389 @default.

• next